汉坦病毒:急诊临床医生的聚焦综述
本文为急诊临床医生聚焦叙述性综述,总结汉坦病毒(含ANDV)的流行病学、临床表现、诊断与处置。感染主要经接触感染啮齿类动物的气溶胶化唾液、粪便或尿液或污染表面传播;近期ANDV暴发显示密切长时间接触下可人传人。潜伏期4–42天。病毒靶向毛细血管和小血管内皮,可致出血热伴肾综合征(主要见于欧亚)或汉坦病毒肺综合征(主要见于美洲)。两者均以非特异病毒前驱期起病;HFRS随后出现凝血异常和尿量改变伴肾功能不全,HPS出现咳嗽、呼吸困难、心动过速和低血压,可进展为呼吸衰竭和心源性休克。诊断采用ELISA检测IgG和IgM抗体。疑诊ANDV者应单间(优选负压)隔离,推荐空气和接触隔离,可考虑类似病毒性出血热的管理策略。治疗以支持为主,包括静脉液体复苏和血管升压药、呼吸支持(如补充氧、无创通气、气管插管)、退热和镇痛、按需止血;可能需要机械通气、ECMO和血液透析。
要点
- 汉坦病毒潜伏期4–42天,初期为非特异病毒前驱期(如发热、寒战、不适、肌痛),急诊需追问旅行与社交史以提高诊断怀疑。
- 疑诊ANDV者应单间隔离(优选负压房间),推荐空气和接触隔离,可考虑类似病毒性出血热的管理策略。
- HFRS主要见于欧亚,前驱期后出现凝血异常和尿量改变伴肾功能不全;HPS主要见于美洲,出现咳嗽、呼吸困难、心动过速和低血压,可进展为呼吸衰竭和心源性休克。
- 诊断采用ELISA检测IgG和IgM抗体。
- 治疗以支持为主:静脉液体复苏和血管升压药、呼吸支持(如补充氧、无创通气、气管插管)、退热和镇痛、按需止血;可能需要机械通气、ECMO和血液透析。
适用人群与场景
- 适用于急诊临床医生评估疑诊汉坦病毒感染(含ANDV)的患者;原文未列出具体纳入/排除人群标准。
诊断标准与关键阈值
- 诊断采用ELISA检测IgG和IgM抗体。
- 临床分型:HFRS主要与欧亚汉坦病毒相关,前驱期后出现凝血异常和尿量改变伴肾功能不全;HPS主要与美洲汉坦病毒相关,出现咳嗽、呼吸困难、心动过速和低血压,可进展为呼吸衰竭和心源性休克。
- 潜伏期4–42天。
处置流程与药物剂量
- 第一步:疑诊ANDV者单间隔离(优选负压房间),推荐空气和接触隔离,可考虑类似病毒性出血热的管理策略。
- 第二步:治疗以支持为主,包括静脉液体复苏和血管升压药。
- 第三步:呼吸支持(如补充氧、无创通气、气管插管)。
- 第四步:退热和镇痛。
- 第五步:按需止血。
- 第六步:可能需要机械通气、ECMO和血液透析。
红旗征与不能漏的情况
- HPS出现咳嗽、呼吸困难、心动过速和低血压,可进展为呼吸衰竭和心源性休克。
- HFRS出现凝血异常和尿量改变伴肾功能不全。
- 疑诊ANDV者需立即单间隔离(优选负压房间),采取空气和接触隔离,可考虑类似病毒性出血热的管理策略。
研究设计与关键结果
- 本文为聚焦叙述性综述,未报告原始研究样本量、中心数、干预对照或主要终点效应量。
证据类型、等级与局限
- 证据类型:聚焦叙述性综述;原文未给出证据等级或推荐强度。
- 局限:叙述性综述,非系统评价,未提供定量合并结果;原文未列出其他局限。
对床旁实践的改变
- 急诊遇非特异病毒前驱期患者应主动追问旅行与社交史,以提示汉坦病毒诊断怀疑。
- 疑诊ANDV者应单间(优选负压)隔离并采取空气和接触隔离,可考虑类似病毒性出血热管理策略。
- 治疗以支持为主,包括静脉液体复苏和血管升压药、呼吸支持、退热镇痛和按需止血;可能需要机械通气、ECMO和血液透析。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Andes virus (ANDV), a form of hantavirus, is a potentially fatal disease with several cases recently reported aboard an expedition cruise ship in April and May 2026.
OBJECTIVE: This focused narrative review provides a focused overview of the epidemiology, clinical presentation, diagnosis, and management of hantavirus infection, including ANDV, for the emergency clinician.
DISCUSSION: Human infections with hantavirus primarily occur through contact with aerosolized particles of saliva, feces, or urine of infected rodents or through touching contaminated surfaces. A recent outbreak of ANDV has demonstrated human-to-human transmission in the setting of close, prolonged contact. The incubation period ranges between 4 and 42 days. As hantaviruses target the endothelium of capillaries and small vessels, patients may develop hemorrhagic fever with renal syndrome, predominantly associated with hantaviruses found in Europe and Asia or hantavirus pulmonary syndrome, mainly associated with hantaviruses in the Americas. Both hemorrhagic fever with renal syndrome and hantavirus with pulmonary syndrome present initially with a non-specific viral prodrome (e.g., fever, chills, malaise, myalgias). Following this prodrome, patients with hemorrhagic fever with renal syndrome can demonstrate coagulation abnormalities and change in urine output with renal dysfunction, while hantavirus with pulmonary syndrome presents with cardiopulmonary symptoms with cough, dyspnea, tachycardia, and hypotension that may progress to respiratory failure and cardiogenic shock. Diagnosis incorporates ELISA assay to detect IgG and IgM antibodies. Patients with concern for ANDV should be isolated in a private room (preferably a negative pressure room). Airborne and contact precautions are recommended; strategies similar to those employed for managing patients with viral hemorrhagic fever may be considered. Treatment is primarily supportive, including resuscitation with intravenous fluids and vasopressors, respiratory support (e.g., supplemental oxygen, noninvasive ventilation, endotracheal intubation), antipyretics and analgesics, and hemorrhage control as needed. Mechanical ventilation, extracorporeal membrane oxygenation, and hemodialysis may be necessary.
CONCLUSION: Hantavirus may initially present with a non-specific viral prodrome, but travel and social history should prompt greater diagnostic suspicion. Patients are managed similarly to those with other viral hemorrhagic fevers.
参考来源
- Chavez S, Molyneux K, Liang SY, et al. Hantavirus: A focused review for the emergency medicine clinician. Am J Emerg Med. 2026. PMID: 42664739. doi:10.1016/j.ajem.2026.08.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。